BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
278 hedge funds and large institutions have $3.94B invested in bluebird bio in 2020 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 119 increasing their positions, 52 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
13% more funds holding
Funds holding: 247 → 278 (+31)
0.67% less ownership
Funds ownership: 8.36% → 7.69% (-0.67%)
14% less call options, than puts
Call options by funds: $39.6M | Put options by funds: $46.1M
Holders
278
Holding in Top 10
4
Calls
$39.6M
Puts
$46.1M
Top Buyers
| 1 | +$136M | |
| 2 | +$90.8M | |
| 3 | +$78.3M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$77.8M |
| 5 |
BlackRock
New York
|
+$67.8M |
Top Sellers
| 1 | -$174M | |
| 2 | -$117M | |
| 3 | -$58.4M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$56.8M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$53.1M |